Difference between revisions of "Abels ER, et al. Cell. Mol. Neurobiol. (2016) cited as Ref 527 in DOI: 10.1038/s41392-020-0110-5 (Q9790)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Cell. Mol. Neurobiol., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Cell. Mol. Neurobiol. | ||
| Property / Published In Name String: Cell. Mol. Neurobiol. / rank | |||
| + | Normal rank | ||
Revision as of 21:03, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Abels ER, et al. Cell. Mol. Neurobiol. (2016) cited as Ref 527 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Abels ER
0 references
Breakefield XO
0 references
2016
0 references
Cell. Mol. Neurobiol.
0 references
